Hong‐Gui Xu

725 total citations
47 papers, 573 citations indexed

About

Hong‐Gui Xu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Hong‐Gui Xu has authored 47 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Hong‐Gui Xu's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Hong‐Gui Xu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Hong‐Gui Xu collaborates with scholars based in China, Germany and United States. Hong‐Gui Xu's co-authors include Wei‐Min Chen, Pinghua Sun, Dongmei Zhang, Jinhui Wu, Guangji Wang, Wen‐Cai Ye, Lei Wang, Jing Lin, Andriy Mokhir and K S Lu and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Journal of Agricultural and Food Chemistry.

In The Last Decade

Hong‐Gui Xu

45 papers receiving 565 citations

Peers

Hong‐Gui Xu

HEMAT

ONCOL

Hidetomo Kikuchi Japan

М.П. Завелевич Ukraine

Estela Maria Novak Brazil

Qin Wu China

André Stander South Africa

Ana Marković Croatia

Lukáš Werner Czechia

Joelle C. Boulos Germany

Ikuko Nakamae Japan

Hidetomo Kikuchi Japan

Hong‐Gui Xu

372 ×1.3

65 ×0.5

46 ×0.7

48 ×0.9

HEMAT

117 ×2.3

ONCOL

Citations per year, relative to Hong‐Gui Xu Hong‐Gui Xu (= 1×) peers Hidetomo Kikuchi

Countries citing papers authored by Hong‐Gui Xu

Since Specialization

Citations

This map shows the geographic impact of Hong‐Gui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Gui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Gui Xu more than expected).

Fields of papers citing papers by Hong‐Gui Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Gui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Gui Xu. The network helps show where Hong‐Gui Xu may publish in the future.

Co-authorship network of co-authors of Hong‐Gui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Gui Xu. A scholar is included among the top collaborators of Hong‐Gui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Gui Xu. Hong‐Gui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Hua‐Qing, Xinyu Li, Han Chen, et al.. (2024). A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia. Stem Cell Research & Therapy. 15(1). 495–495.

Pan, Lili, Li J, Chunfu Li, et al.. (2024). Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia. BMC Cancer. 24(1). 46–46. 4 indexed citations

Oshchepkov, Aleksandr S., Frank Hampel, Hong‐Gui Xu, et al.. (2023). Supramolecular Recognition of Cytidine Phosphate in Nucleotides and RNA Sequences. JACS Au. 3(3). 964–977. 12 indexed citations

Chen, Keke, Xin Tian, Chunfu Li, et al.. (2023). Clinical characteristics and prognosis analysis of patients with de novo ASXL1‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group. Cancer Medicine. 12(12). 13182–13192. 3 indexed citations

Li, Yang, et al.. (2023). Real-World Presentation and Prognostic Effect of Allogeneic Blood Transfusion during the Intensive Induction Phase in Pediatric Acute Lymphoblastic Leukemia. Cancers. 15(18). 4462–4462. 1 indexed citations

Zhou, Dun‐hua, et al.. (2022). Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study. BMC Cancer. 22(1). 1257–1257. 9 indexed citations

Xu, Hong‐Gui, et al.. (2022). 4-Ferrocenylaniline-based ROS-responsive prodrugs with anticancer activity. Journal of Organometallic Chemistry. 964. 122305–122305. 6 indexed citations

Xu, Hong‐Gui, Viktor Reshetnikov, Leoni A. Kunz‐Schughart, et al.. (2021). Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers. Cancers. 14(1). 208–208. 10 indexed citations

Li, Xinyu, Shuting Hu, Yong Liu, et al.. (2021). Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study. Frontiers in Pharmacology. 12. 722502–722502. 7 indexed citations

10.

Huang, Yan, Hao Zheng, Xiaoqin Feng, et al.. (2021). High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia. Frontiers in Oncology. 11. 712747–712747. 3 indexed citations

11.

Kong, Yanan, Anli Yang, Xinxin Xie, et al.. (2020). Impact of the extent of axillary surgery in patients with N2–3 disease in the de-escalation era: a propensity score-matched study. Clinical & Translational Oncology. 23(3). 526–535. 3 indexed citations

12.

Yao, Xi, et al.. (2019). Iron Metabolism and Oxidative Status in Patients with Hb H Disease. Hemoglobin. 43(1). 38–41. 3 indexed citations

13.

J, Li, Xiaoqin Feng, Chunfu Li, et al.. (2019). Effectiveness and Survival of 4 Courses of Chemotheray in 321 Children with Acute Myeloid Leukemia in China: A Multicenter, Nonrandomized Clinical Study. Blood. 134(Supplement_1). 2596–2596. 1 indexed citations

14.

Huang, Ke, Jian‐Pei Fang, Hong‐Gui Xu, et al.. (2018). Reassessment of the Risk-stratified GD-2008 ALL Protocol. Journal of Pediatric Hematology/Oncology. 40(6). 472–477. 2 indexed citations

15.

Xu, Hong‐Gui, Jing Lin, Dongmei Zhang, et al.. (2018). Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. Bioorganic & Medicinal Chemistry Letters. 28(20). 3391–3394. 4 indexed citations

16.

Li, Xinyu, Ke Huang, Dun‐hua Zhou, et al.. (2018). Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post‐hematopoietic cell transplantation in children with thalassemia major. Clinical Transplantation. 33(1). e13459–e13459. 6 indexed citations

17.

Lin, Jing, Zhijian Huang, Hong‐Gui Xu, et al.. (2016). Design, synthesis and anti-inflammatory effects of novel 9-O-substituted-berberine derivatives. MedChemComm. 7(4). 658–666. 27 indexed citations

18.

Zhang, Lin, Hong‐Gui Xu, & Chao Lu. (2013). A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leukemia & lymphoma. 55(6). 1373–1382. 28 indexed citations

19.

Fang, Jianpei, et al.. (2009). PANEL REACTIVE ANTIBODY IN THALASSEMIC SERUM INHIBITS PROLIFERATION AND DIFFERENTIATION OF CORD BLOOD CD34⁺CELLS IN VITRO. Pediatric Hematology and Oncology. 26(5). 338–344. 6 indexed citations

20.

Shen, Jun, et al.. (2008). Bone marrow MR imaging as predictors of outcome in hemopoietic stem cell transplantation. European Radiology. 18(9). 1884–1891. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact